Clinical Study of Solo Tympanostomy Tube Device (TTD)
Post-Market Approval Study of the Solo Tympanostomy Tube Device
2 other identifiers
interventional
20
1 country
1
Brief Summary
This is a multi-centre, single arm study to evaluate the placement of tympanostomy tubes with the AventaMed Solo Tympanostomy Tube Device (TTD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2016
CompletedFirst Posted
Study publicly available on registry
November 7, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedNovember 1, 2017
October 1, 2017
1.8 years
November 4, 2016
October 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative Device Success
Number of ears in which tube placement is achieved with the Solo TTD
Intraoperative
Secondary Outcomes (1)
Conversion from moderate sedation
Intraoperative
Study Arms (1)
Solo TTD
EXPERIMENTALPlacement of tympanostomy tube with Solo TTD
Interventions
Eligibility Criteria
You may qualify if:
- Listed for bilateral tympanostomy tube insertion only
You may not qualify if:
- Anatomy that precludes sufficient visualisation of both the left and right eardrum with the Solo TTD in place.
- Anatomy that precludes safe access to both the left and right eardrum with the Solo TTD
- Patients in whom a reliable audiogram is not possible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nottingham University Hospitals NHS Trustlead
- AventaMed DACcollaborator
- University Hospitals of Derby and Burton NHS Foundation Trustcollaborator
- Sheffield Children's NHS Foundation Trustcollaborator
Study Sites (1)
Nottingham University Hospitals NHS Trust
Nottingham, NG7 2UH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Owen Judd
Royal Derby Hospitals NHS Foundation Trust
- PRINCIPAL INVESTIGATOR
Tawakir Kamani
Sheffield Children's NHS Foundation Trust
- STUDY CHAIR
Matija Daniel
Nottingham University Hospitals NHS Trust
- PRINCIPAL INVESTIGATOR
Anand Kasbekar
Nottingham University Hospitals NHS Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2016
First Posted
November 7, 2016
Study Start
December 1, 2016
Primary Completion
September 1, 2018
Study Completion
November 1, 2019
Last Updated
November 1, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share
No Plan to Share Individual Participant Data